Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 3.29
(4.44%)
CNY 3.29
(4.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 489.26 Million CNY | -31.45% |
| 2022 | 712.51 Million CNY | -18.59% |
| 2021 | 875.18 Million CNY | 33.8% |
| 2020 | 654.11 Million CNY | 35.36% |
| 2019 | 483.24 Million CNY | 65.73% |
| 2018 | 291.58 Million CNY | -44.49% |
| 2017 | 525.26 Million CNY | -28.36% |
| 2016 | 733.24 Million CNY | 26.6% |
| 2015 | 579.16 Million CNY | 18.56% |
| 2014 | 488.49 Million CNY | 26.55% |
| 2013 | 386.01 Million CNY | 24.79% |
| 2012 | 309.32 Million CNY | 83.32% |
| 2011 | 168.73 Million CNY | 26.07% |
| 2010 | 133.83 Million CNY | 45.17% |
| 2009 | 92.19 Million CNY | 21.39% |
| 2008 | 75.95 Million CNY | 71.1% |
| 2007 | 44.39 Million CNY | 476.58% |
| 2006 | 7.69 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 36.81 Million CNY | -57.94% |
| 2024 Q2 | 87.52 Million CNY | 10.38% |
| 2024 Q1 | 79.29 Million CNY | 206.19% |
| 2023 Q3 | 146.46 Million CNY | -26.09% |
| 2023 FY | 488.44 Million CNY | -31.45% |
| 2023 Q1 | 198.14 Million CNY | 16.21% |
| 2023 Q2 | 198.16 Million CNY | 0.01% |
| 2023 Q4 | -74.66 Million CNY | -150.98% |
| 2022 Q2 | 127.2 Million CNY | -50.66% |
| 2022 Q1 | 257.8 Million CNY | 113.12% |
| 2022 Q3 | 156.99 Million CNY | 23.42% |
| 2022 FY | 712.51 Million CNY | -18.59% |
| 2022 Q4 | 170.51 Million CNY | 8.61% |
| 2021 Q4 | 120.96 Million CNY | -48.04% |
| 2021 Q3 | 232.78 Million CNY | -20.5% |
| 2021 Q1 | 228.61 Million CNY | 2026.57% |
| 2021 Q2 | 292.82 Million CNY | 28.08% |
| 2021 FY | 875.18 Million CNY | 33.8% |
| 2020 Q1 | 122.32 Million CNY | 189.14% |
| 2020 Q3 | 297.55 Million CNY | 33.14% |
| 2020 Q4 | 10.75 Million CNY | -96.39% |
| 2020 FY | 654.11 Million CNY | 35.36% |
| 2020 Q2 | 223.48 Million CNY | 82.7% |
| 2019 Q1 | 202.58 Million CNY | 178.46% |
| 2019 Q4 | -137.22 Million CNY | -168.07% |
| 2019 Q3 | 201.58 Million CNY | -6.8% |
| 2019 Q2 | 216.3 Million CNY | 6.77% |
| 2019 FY | 483.24 Million CNY | 65.73% |
| 2018 Q2 | 198.94 Million CNY | 1.24% |
| 2018 FY | 291.58 Million CNY | -44.49% |
| 2018 Q4 | -258.2 Million CNY | -267.31% |
| 2018 Q3 | 154.33 Million CNY | -22.43% |
| 2018 Q1 | 196.51 Million CNY | 3098.26% |
| 2017 FY | 525.26 Million CNY | -28.36% |
| 2017 Q1 | 150.72 Million CNY | -27.64% |
| 2017 Q2 | 182 Million CNY | 20.75% |
| 2017 Q4 | -6.55 Million CNY | -103.29% |
| 2017 Q3 | 199.08 Million CNY | 9.39% |
| 2016 Q3 | 190.87 Million CNY | 3.43% |
| 2016 FY | 733.24 Million CNY | 26.6% |
| 2016 Q4 | 208.3 Million CNY | 9.13% |
| 2016 Q2 | 184.55 Million CNY | 23.44% |
| 2016 Q1 | 149.51 Million CNY | 35.59% |
| 2015 Q3 | 181.51 Million CNY | -3.06% |
| 2015 FY | 579.16 Million CNY | 18.56% |
| 2015 Q2 | 187.25 Million CNY | 87.02% |
| 2015 Q1 | 100.12 Million CNY | -12.02% |
| 2015 Q4 | 110.26 Million CNY | -39.25% |
| 2014 Q4 | 113.79 Million CNY | -6.18% |
| 2014 Q2 | 154.53 Million CNY | 56.31% |
| 2014 Q1 | 98.86 Million CNY | 10.43% |
| 2014 FY | 488.49 Million CNY | 26.55% |
| 2014 Q3 | 121.29 Million CNY | -21.51% |
| 2013 FY | 386.01 Million CNY | 24.79% |
| 2013 Q4 | 89.52 Million CNY | -10.76% |
| 2013 Q1 | 73.92 Million CNY | 24.8% |
| 2013 Q2 | 122.24 Million CNY | 65.36% |
| 2013 Q3 | 100.31 Million CNY | -17.94% |
| 2012 Q4 | 59.23 Million CNY | -36.38% |
| 2012 Q2 | 98.44 Million CNY | 68.17% |
| 2012 Q1 | 58.53 Million CNY | 44.36% |
| 2012 FY | 309.32 Million CNY | 83.32% |
| 2012 Q3 | 93.11 Million CNY | -5.41% |
| 2011 Q2 | 34.26 Million CNY | -3.52% |
| 2011 Q4 | 40.54 Million CNY | -30.57% |
| 2011 FY | 168.73 Million CNY | 26.07% |
| 2011 Q1 | 35.51 Million CNY | -24.22% |
| 2011 Q3 | 58.4 Million CNY | 70.46% |
| 2010 Q2 | 25.13 Million CNY | 52.33% |
| 2010 Q4 | 46.86 Million CNY | 3.37% |
| 2010 Q3 | 45.33 Million CNY | 80.33% |
| 2010 Q1 | 16.5 Million CNY | -46.32% |
| 2010 FY | 133.83 Million CNY | 45.17% |
| 2009 Q2 | 20.01 Million CNY | 67.87% |
| 2009 Q1 | 11.92 Million CNY | -60.59% |
| 2009 FY | 92.19 Million CNY | 21.39% |
| 2009 Q4 | 30.74 Million CNY | 4.13% |
| 2009 Q3 | 29.52 Million CNY | 47.53% |
| 2008 Q3 | 17.13 Million CNY | 0.0% |
| 2008 FY | 75.95 Million CNY | 71.1% |
| 2008 Q4 | 30.24 Million CNY | 76.49% |
| 2007 FY | 44.39 Million CNY | 476.58% |
| 2006 FY | 7.69 Million CNY | 0.0% |